Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group

• by Andrea Jarisch, Seth J. Rotz, Alessandro Cattoni, Blandine Courbiere, Scott D. Lundy, Kyle E. Orwig, Catherine Poirot, Jean-Hugues Dalle, Rachel Phelan, Tamara Diesch-Furlanetto

• May 12, 2026

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

• by Maria D. Guerrero

• May 6, 2026

• 13 min

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS

• by Caihong Qu, Xiaoying Wang

• May 1, 2026

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

• by Mark Davis

• May 6, 2026

• 18 min